GlycoMimetics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch GlycoMimetics and buy or sell other stocks, ETFs, and their options commission-free!

About GLYC

Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company was founded on September 19, 2024 and is headquartered in Waltham, MA. 

CEO
Joshua T. Brumm
CEOJoshua T. Brumm
Employees
26
Employees26
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
Founded
Employees
26
Employees26

GLYC Key Statistics

Market cap
10.25M
Market cap10.25M
Price-Earnings ratio
-0.35
Price-Earnings ratio-0.35
Dividend yield
—
Dividend yield—
Average volume
76.79K
Average volume76.79K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$63.00
52 Week high$63.00
52 Week low
$11.06
52 Week low$11.06

People also own

Based on the portfolios of people who own GLYC. This list is generated using Robinhood data, and it’s not a recommendation.
Tilray Brands
Plug Power
Tonix Pharmaceuticals
Ocugen, Inc
FuelCell Energy
SNDL
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.